Apollomics (APLM) - Uzoq muddatli qarzning kapitalga nisbati

Apollomics Inc. (APLM) tovar belgisi

GURU.Markets tomonidan taqdim etilgan uzoq muddatli qarzdorlikning kapitalga nisbati strukturasi Apollomics, Inc. (APLM) kompaniyasining kombinatsiyalangan terapiyalarni ishlab chiqish uchun AQSh va Xitoy kliniklari bilan hamkorligining ta'sirini ko'rsatadi, bunda 0.00 belgisi asosiy ko'rsatkich vazifasini o'taydi. Biznes asosi patentlar bilan himoyalangan noyob o'pka saratoni mutatsiyalariga qarshi kurashishga tayanadi. Biroq, loyihalar portfelini rivojlantirish sezilarli laboratoriya xarajatlarini talab qiladi, bu esa operatsion richagni cheklaydi.

apollomicsinc.com (APLM): Uzoq muddatli qarzning kapitalga nisbati 21.02.2024dan 28.10.2026gacha

APLM (Apollomics Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Apollomics Corp|APLM - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Apollomics, Inc.|APLM - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Apollomics|APLM - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati apollomicsinc.com|APLM - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Apollomics, Inc.|APLM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Apollomics Corp|APLM - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Apollomics, Inc.|APLM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Apollomics
Kompaniyaning dastlabki tahlili:APLM, apollomicsinc.com
Apollomics, Inc. brendining mahsuloti

Investorlar emitentning moliyaviy barqarorligini tekshirish uchun leveraj koeffitsiyentlaridan foydalanadilar. Uzoq muddatli qarzlarning kapitalga nisbatidagi o'zgarishlarini tahlil qilish orqali uzoq muddatli kreditlarning sof aktivlarga nisbatan ulushini baholash mumkin. Ushbu koeffitsiyentning oshishi kredit riskining ortayotganidan dalolat beradi. Virtual autsorsing modeliga ega bo'lgan Apollomics, Inc. (APLM) uchun past qarz yuklamasi juda muhimdir. Bu shaxsiy ishlab chiqarish korxonalari mavjud bo'lmagan holda patentlarning xavfsizligini ta'minlaydi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd.|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati RVMD (Revolution Medicines Corp)|AAPG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi cgoncology.com CGON|URGN: Uzoq muddatli qarzning kapitalga nisbati|BCAX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PSNL|ERAS (Erasca Oncology) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DCTH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ymabs.com (YMAB)|Aura Biosciences (AURA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti candeltx.com (CADL)|Accuray Inc. - Uzoq muddatli qarzning kapitalga nisbati|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Actuate Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati tuhurabio.com HURA|Protara Therapeutics Inc (TARA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati FATE (Fate Therapeutics Corp)|Uzoq muddatli majburiyatlarning kapitalga nisbati Aadi Bio|Uzoq muddatli qarzning kapitalga nisbati TCRX|Uzoq muddatli qarzning kapitalga nisbati CSBR (championsoncology.com)|XBiotech (XBIT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CEL-SCI Corp. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|OSTX (OS Therapies Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|RADX: Uzoq muddatli majburiyatlarning kapitalga nisbati|artivabio.com (ARTV) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANL (Adlai Nortye) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Veru|Uzoq muddatli qarzning o'z kapitaliga nisbati TPST|Xilio Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati RENB (renovarobio.com)|Mural Oncology - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Kairos Pharma Limited KAPA|Uzoq muddatli qarzning kapitalga nisbati OKUR (OnKure)|GDTC - Uzoq muddatli qarzdorlikning kapitalga nisbati|CRIS (curis.com) - Uzoq muddatli qarzning kapitalga nisbati|THAR (Tharimmune Corporation) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ADVB: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati genprex.com (GNPX)|Calidi Biotherapeutics (CLDI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Sunshine Biopharma Inc. (SBFM)|Uzoq muddatli qarzning kapitalga nisbati XBIO|Salarius Pharma - Uzoq muddatli qarzdorlikning kapitalga nisbati|Purple Biotech (PPBT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|AONC - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|BGNE (BeiGene) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Checkpoint Therapeutics Inc.|ELEV: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati iCAD Corp|Uzoq muddatli qarzning kapitalga nisbati IKNA|Uzoq muddatli qarzning kapitalga nisbati NTBL (notablelabs.com)|Viracta Therapeutics, Inc. (VIRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MorphoSys Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|NAYA - Uzoq muddatli qarzning o'z kapitaliga nisbati|AAPGV: Uzoq muddatli qarzning o'z kapitaliga nisbati